Werbung
Werbung

IART

IART logo

Integra LifeSciences Holdings

13.58
USD
Gesponsert
-0.28
-2.03%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

13.66

+0.08
+0.60%

IART Ergebnisberichte

Positives Überraschungsverhältnis

IART übertreffen die 23 der letzten 40Schätzungen.

57%

Nächster Bericht

Datum des nächsten Berichts
23. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$438.21M
/
$0.81
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+8.99%
/
+50.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-1.00%
/
-16.49%

Integra LifeSciences Holdings earnings per share and revenue

On 30. Okt. 2025, IART reported earnings of 0.54 USD per share (EPS) for Q3 25, beating the estimate of 0.44 USD, resulting in a 21.70% surprise. Revenue reached 402.06 million, compared to an expected 422.54 million, with a -4.85% difference. The market reacted with a -23.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of 0.81 USD, with revenue projected to reach 438.21 million USD, implying an increase of 50.00% EPS, and increase of 8.99% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Integra LifeSciences Holdings reported EPS of $0.54, beating estimates by 21.7%, and revenue of $402.06M, -4.85% below expectations.
The stock price moved down -23.46%, changed from $15.43 before the earnings release to $11.81 the day after.
The next earning report is scheduled for 23. Feb. 2026.
Based on 12 analysts, Integra LifeSciences Holdings is expected to report EPS of $0.81 and revenue of $438.21M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung